BUSINESS● LOW1h ago · Sep 8, 2026, 1:31 PM
'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat
CNBC · global
Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS9m agoMysuru to get international-standard film city: YathindraThe HinduBUSINESS15m agoSamsung's Z8 Fold experiences strong demand ahead of Apple's foldable release: CounterpointSeeking Alpha TechBUSINESS16m agoAmgen drops on Novartis trial setback for heart therapy; BMO downgradesSeeking Alpha TechBUSINESS17m agoExxonMobil's Pioneer launches $2.1B senior notes buyback for cashSeeking Alpha Tech